Search Results 71-80 of 16272 for monoclonal antibody

1. New and novel treatments for hyperlipidemia - Mayo Clinic

   Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...

2. Eculizumab (intravenous route) - Mayo Clinic

   Eculizumab injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program called ...

3. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

4. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic

   This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This medicine helps reduce relapses of MS by ...

5. Anti-interleukin-5 therapy for severe asthma: A new therapeutic option - Mayo Clinic

   Further research is underway to identify other potential targets for asthma monoclonal antibody therapy. For more information. Benralizumab (Fasenra) for ...

6. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

7. Publications - Caroline G. Clune, M.D. - Mayo Clinic

   Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody ...

8. Neuromyelitis optica - Diagnosis and treatment - Mayo Clinic

   A myelin oligodendrocyte glycoprotein immunoglobulin G antibody test, also called an MOG-IgG antibody ... Monoclonal antibodies have been shown in clinical trials ...

9. Muromonab-cd3 (intravenous route) - Mayo Clinic

   Muromonab-CD3 is a monoclonal antibody. It is used to reduce the body's natural immunity in patients who receive organ (for example, kidney) transplants ...

10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...